Medics say unknown drug composition and delayed disclosure left little room to reverse toxicity, warning even small doses can turn deadly
Swapnil Mishra is a Senior Correspondent at various esteemed platforms, including EnterpriseTalk, ITSecurityWire, and The Economic Times. He specializes in themes related to health and wellness, medicine and healthcare, and animal rights, while also covering topics such as consumer health and real estate. His work has been featured in notable publications like The Free Press Journal, PLOS, and APAC News Network.


